Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
Condition(s):Renal Insufficiency, Chronic; ProteinuriaLast Updated:February 22, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Renal Insufficiency, Chronic; ProteinuriaLast Updated:February 22, 2019Unknown status
Condition(s):HypertensionLast Updated:August 23, 2017Unknown status
Condition(s):Heart Failure With Preserved Ejection FractionLast Updated:October 11, 2021Completed
Condition(s):Left Ventricular Hypertrophy; HypertensionLast Updated:January 11, 2021Completed
Condition(s):Myocardial Infarction, Acute; ST Segment Elevation Myocardial Infarction; Non-ST Elevation Myocardial Infarction (nSTEMI)Last Updated:August 8, 2018Unknown status
Condition(s):HealthyLast Updated:September 22, 2008Completed
Condition(s):Chronic Kidney DiseasesLast Updated:October 24, 2023Completed
Condition(s):Atrial Fibrillation; Atrial FlutterLast Updated:September 27, 2013Completed
Condition(s):Proteinuria; Diabetic Nephropathy; Chronic Kidney DiseaseLast Updated:June 3, 2009Completed
Condition(s):Healthy Participants; HypertensionLast Updated:November 29, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.